Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2019

01-08-2019 | Clostridium | Case Report

Community-acquired fulminant colitis caused by binary toxin-producing Clostridium difficile in Japan

Authors: Noriaki Oguri, Akihito Sakuraba, Hiromu Morikubo, Oki Kikuchi, Taro Sato, Soutaro Tokunaga, Shintaro Minowa, Osamu Ikezaki, Tatsuya Mitsui, Miki Miura, Daisuke Saito, Mari Hayashida, Hideaki Mori, Takako Osaki, Shigeru Kamiya, Mitsutoshi Senoh, Haru Kato, Tadakazu Hisamatsu

Published in: Clinical Journal of Gastroenterology | Issue 4/2019

Login to get access

Abstract

We report a case of community-acquired fulminant colitis caused by Clostridium difficile in Japan. A 46-year-old woman was diagnosed with severe infectious enterocolitis and was admitted at another hospital. The stool culture was positive for toxigenic C. difficile. Since the patient presented with fulminant C. difficile infection (CDI) with toxic megacolon, respiratory insufficiency, and circulatory failure, she was transferred to Kyorin University Hospital for intensive care. Intubation and antibiotic therapy were performed. The general condition improved with conservative treatment, and she was discharged without sequelae. While the recovered isolate was toxin A and B-positive and binary toxin-positive, it was identified as polymerase chain reaction (PCR) ribotype ts0592 and slpA sequence type ts0592. The isolate was different from PCR ribotype 027 epidemic in Europe and North America. In Japan, binary toxin-producing strains are rare and have not caused an epidemic to date. Furthermore, there are few data on community-acquired CDI in Japan. In this case, a non-elderly woman with no major risk factors such as antibiotic use, administration of proton pump inhibitor and history of gastrointestinal surgery developed community-acquired fulminant CDI caused by the binary toxin-positive strain, and ICU treatment was required. Further studies focusing on the role of binary toxin-positive C. difficile in the severity of community-acquired CDI are necessary.
Literature
1.
go back to reference Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9.CrossRefPubMed Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9.CrossRefPubMed
2.
go back to reference Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50:194–201.CrossRefPubMed Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50:194–201.CrossRefPubMed
3.
go back to reference Gerding DN, Johnson S, Rupnik M, et al. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes. 2014;5:15–27.CrossRefPubMed Gerding DN, Johnson S, Rupnik M, et al. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes. 2014;5:15–27.CrossRefPubMed
4.
go back to reference Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008;47:1162–70.CrossRefPubMed Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008;47:1162–70.CrossRefPubMed
5.
go back to reference Kato H, Ito Y, van den Berg RJ, et al. First isolation of Clostridium difficile 027 in Japan. Euro Surveill. 2007;12:E070111.3.PubMed Kato H, Ito Y, van den Berg RJ, et al. First isolation of Clostridium difficile 027 in Japan. Euro Surveill. 2007;12:E070111.3.PubMed
6.
go back to reference Mayfield JL, Leet T, Miller J, et al. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31:995–1000.CrossRefPubMed Mayfield JL, Leet T, Miller J, et al. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31:995–1000.CrossRefPubMed
7.
go back to reference Japanese Society of Chemotherapy Committee on Guidelines for Treatment of Anaerobic Infectious. Japanese Association for Anaerobic Infection Research: Chap. 2-12-7. Anaerobic infections (individual fields): antibiotic-associated diarrhea and enterocolitis. J Infect Chemother. 2011;17:137–9.CrossRef Japanese Society of Chemotherapy Committee on Guidelines for Treatment of Anaerobic Infectious. Japanese Association for Anaerobic Infection Research: Chap. 2-12-7. Anaerobic infections (individual fields): antibiotic-associated diarrhea and enterocolitis. J Infect Chemother. 2011;17:137–9.CrossRef
8.
go back to reference Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107:89–95.CrossRefPubMed Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107:89–95.CrossRefPubMed
9.
go back to reference Dial S, Kezouh A, Dascal A, et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179:767–72.CrossRefPubMedPubMedCentral Dial S, Kezouh A, Dascal A, et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179:767–72.CrossRefPubMedPubMedCentral
10.
go back to reference Stubbs SL, Brazier JS, O’Neill HL, et al. PCR targeted to the 16S–23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol. 1999;37:461–3.PubMedPubMedCentral Stubbs SL, Brazier JS, O’Neill HL, et al. PCR targeted to the 16S–23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol. 1999;37:461–3.PubMedPubMedCentral
11.
go back to reference Kato H, Kato H, Ito Y, et al. Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing. J Med Microbiol. 2010;59:556–62.CrossRefPubMed Kato H, Kato H, Ito Y, et al. Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing. J Med Microbiol. 2010;59:556–62.CrossRefPubMed
12.
go back to reference He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013;45:109–13.CrossRef He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013;45:109–13.CrossRef
13.
go back to reference Keel K, Brazier JS, Post KW, et al. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol. 2007;45:1963–4.CrossRefPubMedPubMedCentral Keel K, Brazier JS, Post KW, et al. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol. 2007;45:1963–4.CrossRefPubMedPubMedCentral
14.
go back to reference Nishimura S, Kou T, Kato H, et al. Fulminant pseudomembranous colitis caused by Clostridium difficile PCR ribotype 027 in a healthy young woman in Japan. J Infect Chemother. 2014;20:729–31.CrossRefPubMed Nishimura S, Kou T, Kato H, et al. Fulminant pseudomembranous colitis caused by Clostridium difficile PCR ribotype 027 in a healthy young woman in Japan. J Infect Chemother. 2014;20:729–31.CrossRefPubMed
15.
go back to reference Tagashira Y, Kato H, Senoh M, et al. Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078. J Med Microbiol. 2013;62:1486–9.CrossRefPubMed Tagashira Y, Kato H, Senoh M, et al. Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078. J Med Microbiol. 2013;62:1486–9.CrossRefPubMed
16.
go back to reference Senoh M, Kato H, Fukuda T, et al. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains? J Med Microbiol. 2015;64:1226–36.CrossRefPubMed Senoh M, Kato H, Fukuda T, et al. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains? J Med Microbiol. 2015;64:1226–36.CrossRefPubMed
Metadata
Title
Community-acquired fulminant colitis caused by binary toxin-producing Clostridium difficile in Japan
Authors
Noriaki Oguri
Akihito Sakuraba
Hiromu Morikubo
Oki Kikuchi
Taro Sato
Soutaro Tokunaga
Shintaro Minowa
Osamu Ikezaki
Tatsuya Mitsui
Miki Miura
Daisuke Saito
Mari Hayashida
Hideaki Mori
Takako Osaki
Shigeru Kamiya
Mitsutoshi Senoh
Haru Kato
Tadakazu Hisamatsu
Publication date
01-08-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00949-z

Other articles of this Issue 4/2019

Clinical Journal of Gastroenterology 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine